The U.S. House passed the BIOSECURE Act on Sept 9, 2024, banning federal agencies from purchasing biotech from Chinese firms like WuXi AppTec and BGI.

The BIOSECURE Act, passed by the U.S. House on September 9, 2024, aims to block federal agencies from purchasing biotechnology from foreign adversaries, particularly Chinese firms like WuXi AppTec and BGI. It prohibits contracts with these companies and mandates phasing out existing agreements by January 1, 2032. With bipartisan support, the bill may soon advance to the Senate, impacting U.S.-China biotech relations and potentially increasing costs and delays.

September 26, 2024
6 Articles